These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30272103)

  • 1. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
    Coley N; Raman R; Donohue MC; Aisen PS; Vellas B; Andrieu S
    J Nutr Health Aging; 2018; 22(8):982-998. PubMed ID: 30272103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index.
    Hooper C; De Souto Barreto P; Coley N; Cantet C; Cesari M; Andrieu S; Vellas B
    J Nutr Health Aging; 2017; 21(9):988-993. PubMed ID: 29083439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Blood Cell Omega-3 Fatty Acid Composition and Psychotropic Drug Use in Older Adults: Results from the MAPT Study.
    Gallini A; Yrondi A; Cantet C; Poncet M; Vellas B; Schmitt L; Andrieu S
    J Nutr Health Aging; 2019; 23(9):805-812. PubMed ID: 31641729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
    Welty FK; Daher R; Garelnabi M
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
    Wei BZ; Li L; Dong CW; Tan CC; ; Xu W
    Am J Clin Nutr; 2023 Jun; 117(6):1096-1109. PubMed ID: 37028557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega 3 fatty acid for the prevention of cognitive decline and dementia.
    Sydenham E; Dangour AD; Lim WS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD005379. PubMed ID: 22696350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Plasmatic Polyunsaturated Fatty Acids Concentrations and Cognitive Status and Decline in Neurocognitive Disorders.
    Haution-Bitker M; Gilbert T; Vignoles A; Lecardonnel C; Watelet S; Blond E; Drai J; Bonnefoy M
    J Nutr Health Aging; 2018; 22(6):718-725. PubMed ID: 29806861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT).
    Rolland Y; Barreto PS; Maltais M; Guyonnet S; Cantet C; Andrieu S; Vellas B
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review.
    Andriambelo B; Stiffel M; Roke K; Plourde M
    Ageing Res Rev; 2023 Mar; 85():101835. PubMed ID: 36603691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids and cognitive function.
    Welty FK
    Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ω-3 PUFA for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults: A Randomized Clinical Trial.
    Shinto LH; Murchison CF; Silbert LC; Dodge HH; Lahna D; Rooney W; Kaye J; Quinn JF; Bowman GL
    JAMA Netw Open; 2024 Aug; 7(8):e2426872. PubMed ID: 39088212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term omega-3 supplementation and a lifestyle multidomain intervention on intrinsic capacity among community-dwelling older adults: Secondary analysis of a randomized, placebo-controlled trial (MAPT study).
    Giudici KV; de Souto Barreto P; Beard J; Cantet C; Araujo de Carvalho I; Rolland Y; Vellas B;
    Maturitas; 2020 Nov; 141():39-45. PubMed ID: 33036701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
    Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
    Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
    Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
    Ammann EM; Pottala JV; Robinson JG; Espeland MA; Harris WS
    Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():68-75. PubMed ID: 28651700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores.
    Chhetri JK; de Souto Barreto P; Cantet C; Pothier K; Cesari M; Andrieu S; Coley N; Vellas B
    J Alzheimers Dis; 2018; 64(1):71-78. PubMed ID: 29865075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 Long-Chain Polyunsaturated Fatty Acids: Are They Beneficial for Physical and Cognitive Functioning in Older Adults?
    Erhardt R; Cardoso BR; Meyer BJ; Brownell S; O'Connell S; Mirzaee S; Duckham RL; Macpherson H
    J Nutr Health Aging; 2021; 25(4):454-461. PubMed ID: 33786562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.